Bartley G B, Fatourechi V, Kadrmas E F, Jacobsen S J, Ilstrup D M, Garrity J A, Gorman C A
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota 55905, USA.
Am J Ophthalmol. 1996 Mar;121(3):284-90. doi: 10.1016/s0002-9394(14)70276-4.
To determine the clinical characteristics of an incidence cohort of patients with Graves' ophthalmopathy.
We reviewed the community medical records of 120 patients residing in Olmsted County, Minnesota, in whom Graves' ophthalmopathy was diagnosed between 1976 and 1990.
Among 120 patients with Graves' ophthalmopathy, 108 (90%) patients had Graves' hyperthyroidism, one (1%) had primary hypothyroidism, four (3%) had Hashimoto's thyroiditis, and seven (6%) were euthyroid. At some point in their clinical course, eyelid retraction was present in 108 patients, whereas the approximate frequency of exophthalmos was 62% (73 patients); restrictive extraocular myopathy, 43% (51 patients); and optic nerve dysfunction, 6% (seven patients). Only six (5%) patients had eyelid retraction, exophthalmos, optic nerve dysfunction, extraocular muscle involvement, and hyperthyroidism. At the time of diagnosis of ophthalmopathy, upper eyelid retraction and eyelid lag were documented in 85 and 52 patients, respectively, and the most frequent ocular symptom was pain (36 patients, 30%). Diplopia was noted at the initial examination by 20 patients, lacrimation was present in 25 patients, 19 patients had photophobia, and nine patients had blurred vision. Decreased vision from optic neuropathy was present in less than 2% of eyes at the time of diagnosis. Thyroid dermopathy and acropachy accompanied Graves' ophthalmopathy in five patients (4%) and one (1%) patient, respectively. Myasthenia gravis occurred in only one patient.
Eyelid retraction is the most common clinical sign of Graves' ophthalmopathy. The complete constellation of typical features (hyperthyroidism, eyelid retraction, exophthalmos, restrictive extraocular myopathy, and optic nerve dysfunction) occurs relatively infrequently.
确定格雷夫斯眼病发病队列患者的临床特征。
我们查阅了明尼苏达州奥尔姆斯特德县120名患者的社区医疗记录,这些患者在1976年至1990年间被诊断为格雷夫斯眼病。
120例格雷夫斯眼病患者中,108例(90%)患有格雷夫斯甲亢,1例(1%)患有原发性甲状腺功能减退,4例(3%)患有桥本甲状腺炎,7例(6%)甲状腺功能正常。在其临床病程的某个阶段,108例患者出现眼睑退缩,突眼的大致发生率为62%(73例);限制性眼外肌病,43%(51例);视神经功能障碍,6%(7例)。只有6例(5%)患者同时出现眼睑退缩、突眼、视神经功能障碍、眼外肌受累和甲亢。在眼病诊断时,分别有85例和52例患者记录有上睑退缩和眼睑滞后,最常见的眼部症状是疼痛(36例,30%)。初诊时20例患者有复视,25例患者有流泪,19例患者有畏光,9例患者有视力模糊。诊断时因视神经病变导致视力下降的眼睛不到2%。5例(4%)和1例(1%)患者的格雷夫斯眼病分别伴有甲状腺皮肤病变和杵状指。重症肌无力仅发生在1例患者中。
眼睑退缩是格雷夫斯眼病最常见的临床体征。典型特征(甲亢、眼睑退缩、突眼、限制性眼外肌病和视神经功能障碍)的完整组合相对少见。